Top Nasdaq Stocks is issuing a report on four stocks to watch. Bioline RX Ltd (NASDAQ:BLRX), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Solazyme Inc (NASDAQ:SZYM), and ITT Educational Services, Inc. (NYSE:ESI) have been added to our watch list today. Continue reading to find out why. – To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
Bioline RX Ltd (NASDAQ:BLRX) was up over 20% in pre market trading on Tuesday (3/15) and is up more than 40% since early February. The company is a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates. Last week BLRX announced their 2015 operating results in which company CEO, Kinneret Savitsky, Ph.D. stated, “015 was a year of significant progress for BioLineRx on several fronts, as we advanced our lead therapeutic clinical programs both from a development and regulatory perspective, and entered into an exciting new collaboration in the immuno-oncology space.”
Stay Informed and Up To Date On The Hottest NASDAQ Plays like BLRX. Get Them Here
Orexigen Therapeutics, Inc. (NASDAQ:OREX) also saw strong pre market trading. Today the company, jointly with Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) announced they have agreed to acquire the United States rights for CONTRAVE®, a treatment for weight management. Orexigen and Takeda have agreed to a six-month transition period, during which time Takeda is required to continue to commercialize Contrave in the United States. The stock is up over 30% in the last 2 days following this news.
Members of record by 4PM March 14 will secure a place holder to receive our next report. Get Your Free Membership Now.
Solazyme Inc (NASDAQ:SZYM) an earnings call last night (3/14). “We’ve announced several significant developments since Friday, and I’ll summarize them briefly: The signing of a strategic financing round of approximately $28 million with a group of leading investors and entrepreneurs in food and nutrition innovation; key Management and Board appointments that, along with our new investor group, will broadly expand TerraVia’s market knowledge in the food and nutrition arena; and a crucial, new $200-million-plus supply agreement with Unilever,” stated Jonathan Wolfson, Solazyme, Inc., CEO. “This agreement is a major expansion of our long-running partnership that is expected to serve as a cornerstone of our specialty personal care ingredients business, and provides a cost-plus base load that de-risks the plant, and makes everything that follows more profitable.”
The stock closed Monday (3/14) at $1.90 and has made highs early Tuesday morning of $2.77 marking a move of $0.87 per share; roughly 46%.
Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word “NASDAQ” to 77948
ITT Educational Services, Inc. (NYSE:ESI) is a leading provider of technology-oriented postsecondary degree programs. On Monday (3/14) the company reported its fourth quarter and full year operating results. New student enrollment in the fourth quarter of 2015 decreased 17.1% to 10,478 compared to 12,639 in the same period in 2014. Total student enrollment decreased 16.3% to 44,922 as of December 31, 2015 compared to 53,646 as of December 31, 2014. Despite these results, management remained optimistic with regard to their ability to develop more efficient means of doing business. The stock has moved up nearly 40% within the last 2 days following these results..
Stay Informed and Up To Date On The Hottest NASDAQ and NYSE Plays. Get Them Here
Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don’t forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text “NASDAQ” to 77948.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.
Top Nasdaq Stocks
SOURCE: Top Nasdaq Stocks